Phase I data disclosed on XOMA-052, a new anti-inflammatory approach for type 2 diabetes therapy June 22, 2009
Novel angiotensin receptor blocker K-868 active against experimental diabetic nephropathy June 19, 2009
MacroGenics and Lilly complete enrollment in phase II/III trial of teplizumab in diabetes June 19, 2009
Safety committee recommends continuation of BioSante's phase III study of LibiGel in HSDD June 18, 2009
RSS